Noxopharm has adopted rigorous systems of control, review and accountability as the basis for the administration of corporate governance. The Board is committed to administering its corporate governance policies and procedures with openness and integrity.

The Board seeks, where appropriate, to provide accountability levels that meet or exceed the ASX Corporate Governance Council’s Principles and Recommendations.  Copies of the Company’s corporate governance procedures, policies and practices can be found by clicking on the links below:

 Audit and Risk Committee Charter

 Board Charter

 Code of Conduct

 Communication and Disclosure Policy

 Diversity and Inclusion Policy

 Remuneration and Nomination Committee Charter

 Risk Management Policy

 Securities Trading Policy

 Constitution

 Noxopharm Public Company Constitution

 Whistleblower Policy

 Anti-Bribery and Corruption Policy

 FY23 Board Skills Matrix Summary

 FY23 Corporate Governance Statement and Appendix 4G